– Ten63’s AI/ML Platform Will be Applied to Multiple Disease Areas of Focus within Boehringer’s Research and Development Portfolio – DURHAM, N.C., Dec. 6, 2023 /PRNewswire/ — Ten63 Therapeutics, a biotechnology company unlocking previously undruggable targets by leveraging proprietary…